Is acetylcholine an autocrine/paracrine growth factor via the nicotinic α7-receptor subtype in the human colon cancer cell line HT-29?

European Journal of Pharmacology

Volumn 609, Issue 1-3, 2009, Pages 27-33

  Pettersson, Ann ^a   Nilsson, Linn ^b   Nylund, Gunnar ^c   Khorram Manesh, Amir ^d   Nordgren, Svante ^d   Delbro, Dick S ^a,d,e  

^a LINNAEUS UNIVERSITY   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c BORÅS HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e KARLSTAD UNIVERSITY   (Sweden)

Author keywords

Acetylcholine; Acetylcholine esterase; Alpha7; Choline acetyltransferase; HT 29 human colon cancer cell line; Nicotinic receptor

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; BUNGAROTOXIN RECEPTOR; CHOLINE ACETYLTRANSFERASE;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL GROWTH; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AUTOCRINE COMMUNICATION; BIOTINYLATION; CELL LINE, TUMOR; CHOLINE O-ACETYLTRANSFERASE; COLONIC NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PARACRINE COMMUNICATION; RECEPTORS, NICOTINIC;

EID: 64549105660     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.002     Document Type: Article

References (38)

1. Brown J.H., and Taylor P. Muscarinic receptor agonists and antagonists. In: Hartman J.G., and Limbird L.E. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. (2001), McGraw-Hill, New York 155-173
2. Chen D., and Patrick J.W. The α-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the α7 subunit. J. Biol. Chem. 272 (1997) 24024-24029
3. Cheng K., Zimniak P., and Raufman J.-P. Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. Cancer Res. 63 (2003) 6744-6750
4. Cheng K., Samimi R., Xie G., Shant J., Drachenberg C., Wade M., Davis R.J., Nomikos G., and Raufman J.-P. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. Am. J. Physiol. Gastrointest. Liver Physiol. 295 (2008) G591-G597
5. de Jonge W.J., and Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br. J. Pharmacol. 151 (2007) 915-929
6. Deng R., Li W., Guan Z., Zhou J.-M., Wang Y., Mei Y.-P., Li M.-T., Feng G.-K., Huang W., Liu Z.-C., Han Y., Zeng Y.-X., and Zhu X.-F. Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis. Oncogene 25 (2006) 7070-7077
7. Espanol A.J., de la Torre E., Fiszman G.L., and Sales M.E. Role of non-neuronal cholinergic system in breast cancer progression. Life Sci. 80 (2007) 2281-2285
8. Falugi C., Castellani P., Raffanti S., Borsi L., and Zardi L. Acetylcholinesterase in normal and malignant human cells. Basic Appl. Histochem. 30 (1986) 433-446
9. Frucht H., Jensen R.T., Dexter D., Yang W.-L., and Xiao Y. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Clin. Cancer Res. 5 (1999) 2532-2539
10. Giunta B., Ehrhart J., Townsend K., Sun N., Vendrame M., Shytle D., Tan J., and Fernandez F. Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain Res. Bull. 64 (2004) 165-170
11. Goetzl E.J. Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands. FASEB J. 21 (2007) 638-642
12. Grando S.A. Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors. J. Pharmacol. Sci. 106 (2008) 174-179
13. Gregory R.L., and Gfell L.E. Effect of nicotine on secretory component synthesis by secretory epithelial cells. Clin. Diagn. Lab. Immunol. 3 (1996) 578-583
14. Hoffman B.B., and Taylor P. Neurotransmission: the autonomic and somatic motor systems. In: Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. (2001), McGraw-Hill, New York 115-153
15. Horiuchi Y., Kimura R., Kato N., Fujii T., Seki M., Endo T., Kato T., and Kawashima K. Evolutional study on acetylcholine expression. Life Sci. 72 (2003) 1745-1756
16. Jacobsson J., Persson M., Hansson E., and Rönnbäck L. Corticosterone inhibits expression of the microglial glutamate transporter GLT-1 in vitro. Neuroscience 139 (2006) 475-483
17. Kawashima K., Yoshikawa K., Fujii Y.X., Moriwaki Y., and Misawa H. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci. 80 (2007) 2314-2319
18. Klapproth H., Reinheimer T., Metzen J., Münch M., Bittinger F., Kirkpatrick C.J., Höhle K.D., Schemann M., Racké K., and Wessler I. Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch. Pharmacol. 355 (1997) 515-523
19. Kopp R., and Pfeiffer A. Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells. Cancer Res. 50 (1990) 6490-6496
20. Kopp R., Lambrecht G., Mutschler E., Moser U., Tacke R., and Pfeiffer A. Human HT-29 colon carcinoma cells contain muscarinic M3 receptors coupled to phosphoinositide metabolism. Eur. J. Pharmacol. 172 (1989) 397-405
21. Lind G.J., and Cavanagh H.D. Nuclear muscarinic acetylcholine receptors in corneal cells from rabbit. Invest. Ophthalmol. Vis. Sci. 34 (1993) 2943-2952
22. Millar N.S., and Harkness P.C. Assembly and trafficking of nicotinic acetylcholine receptors. Mol. Membr. Biol. 25 (2008) 279-292
23. Pettersson A., Nilsson L., Edsparr K., Nylund G., Khorram-Manesh A., Albertsson P., Nordgren S., and Delbro D. Is acetylcholine an autocrine growth factor in human colon cancer cells?. Virchows Arch. 452 Suppl 1 (2008) P-354
24. Picciotto M.R., Caldarone B.J., Brunzell D.H., Zachariou V., Stevens T.R., and King S.L. Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol. Ther. 92 (2001) 89-108
25. Santos S.C., Vala I., Miguel C., Barata J.T., Garção P., Agostinho P., Mendes M., Coelho A.V., Calado A., Oliveira C.R., e Silva J.M., and Saldanha C. Expression and subcellular localization of a novel nuclear acetylcholinesterase protein. J. Biol. Chem. 282 (2007) 25597-25603
26. Sastry B.V.R., and Sadavongvivad C. Cholinergic systems in non-nervous tissues. Pharmacol. Rev. 30 (1978) 65-132
27. Song P., Sekhon H.S., Jia Y., Keller J.A., Blusztajn J.K., Mark G.P., and Spindel E.R. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res. 63 (2003) 214-221
28. Summers A.E., Whelan C.J., and Parson M.E. Nicotinic acetylcholine receptor subunits and receptor activity in the epithelial cell line HT29. Life Sci. 72 (2003) 2091-2094
29. Taylor P. Agents acting at the neuromuscular junction and autonomic ganglia. In: Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. (2001), McGraw-Hill, New York 193-213
30. Trombino S., Bisio A., Catassi A., Cesario A., Falugi C., and Russo P. Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: possibility of new therapeutic strategies. Curr. Med. Chem. Anticancer Agents 4 (2004) 535-542
31. Wang H., and Sun X. Desensitized nicotinic receptors in brain. Brain Res. Brain Res. Rev. 48 (2005) 420-437
32. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., and Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (2003) 384-388
33. Wessler I.K., and Kirkpatrick C.J. The non-neuronal cholinergic system: an emerging drug target in the airways. Pulm. Pharmacol. Ther. 14 (2001) 423-434
34. Wessler I., and Kirkpatrick C.J. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br. J. Pharmacol. 154 (2008) 1558-1571
35. Wessler I., Kilbinger H., Bittinger F., Unger R., and Kirkpatrick C.J. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci. 72 (2003) 2055-2061
36. Wong H.P., Yu L., Lam E.K., Tai E.K., Wu W.K., and Cho C.-H. Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol. Appl. Pharmacol. 221 (2007) 261-267
37. Yang W.-L., and Frucht H. Cholinergic receptor up-regulates COX-2 expression and prostaglandin E2 production in colon cancer cells. Carcinogenesis 21 (2000) 1789-1793
38. Yang L., He H.-Y., and Zhang X.-J. Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cells. Neurosci. Res. 42 (2002) 261-268